The increased number of deceased donor liver transplants related to alcoholic hepatitis — up more than 50 percent over predicted numbers — was associated with rising alcohol sales.

Although the drug is commonly used to treat hepatorenal syndrome in other parts of the world, it lacks FDA approval. Researchers examine both its efficacy and safety.

A team explores the protective capabilities of consuming a diet enriched with fructose when it comes to acetaminophen overdose in mice.

An international team of researchers conducts a study that defines a simple, low-cost blood test that yields high-performing results in the elimination of hepatitis C.

A collaborative U-M team shows that liver injury is less likely to originate from popular cancer immunotherapy drug, pembrolizumab, than tumor progression.

An enzyme’s newly discovered ability to spur the body to prevent or repair acute liver injury in mice could be harnessed as a therapy or used as a biomarker.<